4.5 Article

Inhibition by KMI-574 Leads to Dislocalization of BACE1 From Lipid Rafts

期刊

JOURNAL OF NEUROSCIENCE RESEARCH
卷 87, 期 2, 页码 360-368

出版社

WILEY
DOI: 10.1002/jnr.21858

关键词

BACE1; Alzheimer's disease; lipid raft; protein transport; inhibitor

资金

  1. Ministry of Health, Labor and Welfare, Japan
  2. Takeda Chemical Industries, Ltd. (Osaka, Japan)

向作者/读者索取更多资源

BACE1 initiates processing of the amyloid precursor protein (APP) in the production of amyloid beta (A beta) peptide. After P-cleavage by BACE1, the C-terminal stub of the APP fragment is further processed by the gamma-secretase complex to produce A beta. Because APP, A beta, the -ysecretase complex, and BACE1 are found in lipid raft membranes, A beta production is widely accepted to occur in lipid rafts. However, whether BACE1 is activated within the rafts is unclear. To analyze the relationship between the activity and the localization of BACE1, we used a new BACE1 inhibitor, KMI-574, and separated raft membranes on sucrose density gradients. In the presence of KMI-574, the localization of BACE1 shifted from the rafts to nonraft membranes in HEK293 cells. We also analyzed the proteolytically inactive mutants, D93A, D289A, and D93A/D289A, of BACE1. These mutants also moved from rafts to nonrafts, and the D93A/D289A double-mutant localized exclusively to nonraft membranes. The mutants were defective in maturation by glynosylation and formed hyperoligomers, suggesting that the BACE1 oligomers could not exit from the ER and be transported to the Golgi apparatus. Our findings suggest that the activated conformation of BACE1 is important for protein transport and localization to lipid rafts. (c) 2008 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据